Head-to-head · Value Score
EdgeRx vs Henry Meds
Two GLP-1 deals, scored on the same six factors. EdgeRx lands a Value Score of 82, Henry Meds a 78. Here's who gives you the honest lower price — and where each one bites back.
EdgeRx
#50 · Grade B+ · Good Value
Est. first month
$229/mo
Save ~83% vs brand-nameHenry Meds
#94 · Grade B- · Fair Price
Est. first month
$249/mo
Save ~82% vs brand-nameThe verdict
EdgeRx takes it on Value Score, 82 to 78 — an est. $229/mo first month, with no teaser step-up baked in. Henry Meds isn't out of it: People who want a simple, well-known flat-fee program and will pay a premium for it.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | EdgeRx | Henry Meds |
|---|---|---|
| Value Score | 82 (B+) | 78 (B-) |
| Est. first month | $229/mo | $249/mo |
| Save vs brand-name | ~83% | ~82% |
| Semaglutide | $229/mo injectable | $249/mo |
| Tirzepatide | $299/mo injectable | $349/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | 46 states (excludes Arkansas, Indiana, Minnesota, South Carolina) | Multi-state |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
EdgeRx
A men's-only protocol shop with flat, disclosed GLP-1 pricing, a named Chief Medical Advisor, and a named 503A compounding pharmacy — rare transparency for this tier of the ranking.
Why it's a deal
- Both molecules disclosed up front — semaglutide $229/mo, tirzepatide $299/mo, both once-weekly injectable with free shipping and no separate physician fee
- Named compounding pharmacy — Strive Pharmacy, 503A, operating since 2018 — most peers name none
- Named Chief Medical Advisor, Dr. John Starke, MD (ABEM board-certified)
- LegitScript certified
The fine print
- Men-only — not built for, or marketed to, women or other readers
- The named Chief Medical Advisor does not personally prescribe; the actual prescribing pool is unnamed licensed physicians
- Third-party lab testing is claimed but no specific lab is named
- Excludes Arkansas, Indiana, Minnesota, and South Carolina
Henry Meds
The flat-fee pioneer: honest, no step-ups — just priced at the higher end of the market now.
Why it's a deal
- Simple flat-fee model with no teaser step-ups
- Well-established brand
- Both molecules
The fine print
- Higher pricing than most newer entrants
- Compounded only
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores EdgeRx is ranked on the EdgeRx alternatives ranking, and the same list for the other side is on alternatives to Henry Meds.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.